Literature DB >> 29196826

Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea.

Rohit Verma1, Kuljeet Singh Anand2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29196826     DOI： 10.1007/s00213-017-4795-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  13 in total

1.  Drooling in Parkinson's disease: a novel tool for assessment of swallow frequency.

Authors:  L Marks; J Weinreich
Journal:  Int J Lang Commun Disord       Date:  2001       Impact factor: 3.020

2.  Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of life.

Authors:  Senan Maher; Aoife Cunningham; Niamh O'Callaghan; Fintan Byrne; Colm Mc Donald; Shane McInerney; Brian Hallahan
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-30

Review 3.  Botulinum toxin for the treatment of sialorrhea: a meta-analysis.

Authors:  Rishi Vashishta; Shaun A Nguyen; David R White; M Boyd Gillespie
Journal:  Otolaryngol Head Neck Surg       Date:  2012-10-30       Impact factor: 3.497

4.  Three treatment approaches and clinical factors in the reduction of drooling.

Authors:  N Thomas-Stonell; J Greenberg
Journal:  Dysphagia       Date:  1988       Impact factor: 3.438

Review 5.  [Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature].

Authors:  K G Kahl; P Trillenberg; A Kordon; R Lencer; C Klein; J Hagenah
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

6.  Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.

Authors:  Susanne Steinlechner; Christine Klein; Andreas Moser; Rebekka Lencer; Johann Hagenah
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

7.  Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.

Authors:  Babur Yusufi; Sujoy Mukherjee; Robert Flanagan; Carol Paton; Graham Dunn; Eleanor Page; Thomas R E Barnes
Journal:  Int Clin Psychopharmacol       Date:  2007-07       Impact factor: 1.659

8.  Botulinum toxin as an effective treatment of clozapine-induced hypersalivation.

Authors:  Kai G Kahl; Johann Hagenah; Silke Zapf; Peter Trillenberg; Christine Klein; Rebekka Lencer
Journal:  Psychopharmacology (Berl)       Date:  2004-01-28       Impact factor: 4.530

9.  Psychiatrists' attitude towards and knowledge of clozapine treatment.

Authors:  J Nielsen; M Dahm; H Lublin; D Taylor
Journal:  J Psychopharmacol       Date:  2009-01-22       Impact factor: 4.153

Review 10.  Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Authors:  Amanda Amrita Lakraj; Narges Moghimi; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2013-05-21       Impact factor: 4.546
View more
  2 in total

Review 1.  Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Authors:  Armin Steffen; Wolfgang Jost; Tobias Bäumer; Dirk Beutner; Sabine Degenkolb-Weyers; Martin Groß; Maria Grosheva; Samer Hakim; Kai G Kahl; Rainer Laskawi; Rebekka Lencer; Jan Löhler; Thekla Meyners; Saskia Rohrbach-Volland; Rainer Schönweiler; Sara-Christina Schröder; Sebastian Schröder; Heidrun Schröter-Morasch; Maria Schuster; Susanne Steinlechner; Roland Urban; Orlando Guntinas-Lichius
Journal:  J Neural Transm (Vienna)       Date:  2019-04-10       Impact factor: 3.575

Review 2.  Therapy of Sialorrhea with Botulinum Neurotoxin.

Authors:  Wolfgang H Jost; Tobias Bäumer; Rainer Laskawi; Jaroslaw Slawek; Björn Spittau; Armin Steffen; Martin Winterholler; Ganesh Bavikatte
Journal:  Neurol Ther       Date:  2019-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.